Follow
Vanessa F. Moreira Ferreira
Vanessa F. Moreira Ferreira
Research Fellow, Harvard Medical School
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Peripheral nerve injuries: A retrospective survey of 1124 cases
JA Kouyoumdjian, CR Graça, VFM Ferreira
Neurology India 65 (3), 551-555, 2017
1072017
Time perception and age
VFM Ferreira, GP Paiva, N Prando, CR Graça, JA Kouyoumdjian
Arquivos de neuro-psiquiatria 74, 299-302, 2016
262016
Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
VF Moreira Ferreira, D Meredith, JM Stankiewicz
Neurology: Neuroimmunology & Neuroinflammation 6 (5), e589, 2019
142019
A possible case of serum sickness after ocrelizumab infusion
VF Moreira Ferreira, DJ Kimbrough, JM Stankiewicz
Multiple Sclerosis Journal 27 (1), 155-158, 2021
112021
Carpal tunnel syndrome electrophysiological parameters acquired using the e-norms technique
J Jabre, J Kouyoumdjian, VF Moreira Ferreira
MUSCLE & NERVE 54 (3), 546-546, 2016
62016
Quantitation of muscle pathology abnormalities in 18 patients with mitochondrial disorders
JA Kouyoumdjian, CR Graça, VFM Ferreira
Jornal Brasileiro de Patologia e Medicina Laboratorial 54, 325-332, 2018
52018
Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis
G Bose, BC Healy, C Barro, VF Moreira Ferreira, S Saxena, BI Glanz, ...
Multiple Sclerosis Journal 29 (11-12), 1418-1427, 2023
32023
Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis
VF Moreira Ferreira, Y Liu, BC Healy, JM Stankiewicz
Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (2 …, 2021
32021
Facial Palsy: A Retrospective Study of 416 Cases Based on Electrodiagnostic Consultation
VFM Ferreira, CR Graça, JA Kouyoumdjian
The Open Neurology Journal 14 (1), 2020
22020
Prognostic value of neurofilament light and glial fibrillary acidic protein for disability worsening PIRA by age range in multiple sclerosis
C Barro, BC Healy, G Bose, H Lokhande, S Saxena, VF Ferreira, ...
MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 306-306, 2022
12022
Serum NfL and GFAP biomarker analysis in early high versus low efficacy DMT paradigms for MS (P1-1. Virtual)
VFM Ferreira, J Zurawski, BC Healy, S Saxena, A Paul, F Saleh, Y Liu, ...
Neurology 98 (18 Supplement), 2022
12022
Serum GFAP and long-term outcomes in high efficacy versus low efficacy early treatment in multiple sclerosis
VF Ferreira, J Zurawski, BC Healy, S Saxena, A Paul, F Saleh, Y Liu, ...
MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 355-355, 2022
2022
Efficacy and safety of dimethyl fumarate in progressive multiple sclerosis
VF Ferreira, Y Liu, B Healy, J Stankiewicz
MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 532-532, 2020
2020
Teriflunomide safety and efficacy in advanced progressive multiple sclerosis
VF Moreira Ferreira, D Caefer, N Erlich-Malona, BC Healy, T Chitnis, ...
Multiple Sclerosis International 2020 (1), 5471987, 2020
2020
A possible case of serum sickness-like reaction after ocrelizumab
VF Ferreira, D Kimbrough, J Stankiewicz
MULTIPLE SCLEROSIS JOURNAL 25, 545-545, 2019
2019
FACIAL PALSY: A RETROSPECTIVE STUDY OF 416 CASES BASED ON ELECTRONEUROMYOGRAPHY
VF Moreira Ferreira, CR Graca, JA Kouyoumdjian
MUSCLE & NERVE 60, S15-S15, 2019
2019
Quantificação das anormalidades patológicas musculares em 18 pacientes com desordens mitocondriais
JA Kouyoumdjian, CR Graça, VFM Ferreira
Jornal Brasileiro de Patologia e Medicina Laboratorial 54, 325-332, 2018
2018
PERIPHERAL NERVE INJURIES: A RETROSPECTIVE SURVEY OF 1124 CASES
J Kouyoumdjian, C Graca, V Ferreira
MUSCLE & NERVE 54 (3), 604-604, 2016
2016
Percepção do tempo e idade
VFM Ferreira, GP Paiva, N Prando, CR Graça, JA Kouyoumdjian
Arquivos de Neuro-Psiquiatria 74, 299-302, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–19